Australian-Singaporean regenerative medicine company Osteopore Limited (ASX: OSX; Osteopore or the Company) – a global leader in 3D-printed biomimetic and bioresorbable implants – is delighted to announce the opening of a Clinical Centre of Excellence (CCoE) for medial wedge opening high tibial osteotomy (MOWHTO), in partnership with Total Orthopaedic Care & Surgery’s Dr Hamid Razak.
Highlights
- Osteopore sets up clinical centre of excellence (CCoE) for medial wedge opening high tibial osteotomy (MOWHTO) with Total Orthopaedics.
- Distinguished consultant orthopaedic surgeon Dr Hamid Razak, a key opinion leader on Osteopore’s clinical advisory panel, will lead the CCoE.
- The CCoE is focused on medial wedge opening high tibial osteotomy (MOWHTO) and post-surgery rehabilitation.
This announcement comes on the back of the recent approval of Osteopore’s orthopaedic product in Singapore and the signing of DKSH as a strategic partner, highlighting our ongoing commitment to advancing orthopaedic care and improving patient outcomes in knee preservation.
Dr Hamid, a distinguished consultant orthopaedic surgeon with more than 15 years of experience, also serves as an Adjunct Associate Professor at Duke-NUS Medical School. He is a key opinion leader (KOL) on Osteopore’s clinical advisory board, contributing his vast expertise to the CCoE.
Previously, Dr Hamid led Sports & Joint Preserving Osteotomy Services at Sengkang General Hospital and served as the site chief for the SingHealth Sports & Exercise Medicine Centre. Dr Hamid has completed fellowships at Imperial College London and the London Knee Osteotomy Centre and has been awarded the prestigious College Travelling Fellowship by Glasgow’s Royal College of Physicians & Surgeons, as well as the ICRS Clinical Travelling Fellowship. His extensive training includes proficiency in joint preservation procedures and the use of the Oxford Partial Knee implant.
This CCoE is dedicated to improving the understanding and adoption of MOWHTO among clinicians for relevant patients. The CCoE will serve as a training hub, providing educational sessions led by Dr Hamid, focusing on the MOWHTO technique and post-surgery rehabilitation protocols, ensuring clinicians are equipped to deliver optimal care.
MOWHTO is one of the surgical options under the broader category of knee preservation techniques. These techniques are gaining popularity globally as they offer joint preservation and minimal trauma, effectively delaying the need for total knee arthroplasty (TKA) by several years. Recent studies highlight the growing trend in knee preservation, emphasising advancements in surgical strategies and technologies that enhance patient outcomes.
Osteopore’s MOWHTO product was compared in a head-to-head clinical study against allogeneic femoral head grafts, outperforming the allogeneic grafts in bone union.
The MOWHTO market is expected to grow at a CAGR of 9.2%, with procedures projected to reach 35,000 annually in the Asia Pacific region (APAC) by 2025 according to market research.
“Training and education are vital to ensuring that innovative products are used with the most appropriate surgical techniques.
“We are honoured to have Dr Hamid’s expertise in knee preservation and MOWHTO, and we look forward to a successful partnership.”
Commenting on this partnership, Dr Hamid Razak, said:
“I am dedicated to advancing knee preservation through collaborative research and innovation with like-minded surgeons, researchers, and industry partners.
“Establishing this Centre with Osteopore is a natural step in this mission. I look forward to a strong partnership that will drive innovation and enhance patient care in knee preservation.”
